CLINICAL_TRIALS
withdrawal
· 2019-01-17
Clinical Trial Update: A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults [Phase 2]
Summary
A Phase 2 trial evaluating a botanical drug containing East Indian Sandalwood Oil for plaque psoriasis in adults has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santalis Pharmaceuticals, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: WITHDRAWN